These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31522552)

  • 1. Global Nature of Incipient Chamber Remodeling and Dysfunction in Diabetic Individuals Living in the Community: Potential Mechanisms.
    Xie E; Lima JAC
    Circ Cardiovasc Imaging; 2019 Sep; 12(9):e009729. PubMed ID: 31522552
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicted Heart Mass for Donor Organ Allocation: Getting Closer to the Target.
    Tremblay-Gravel M; Khush K
    Circ Heart Fail; 2019 Dec; 12(12):e006634. PubMed ID: 31805782
    [No Abstract]   [Full Text] [Related]  

  • 3. Obesity-associated mortality risk: Chronic kidney disease in focus.
    Spatola L; Dozio E
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):212-213. PubMed ID: 30642792
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study.
    Ng AC; Auger D; Delgado V; van Elderen SG; Bertini M; Siebelink HM; van der Geest RJ; Bonetti C; van der Velde ET; de Roos A; Smit JW; Leung DY; Bax JJ; Lamb HJ
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):51-9. PubMed ID: 22135399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?
    Pitt B; Zannad F
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):9-11. PubMed ID: 22253334
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetic cardiomyopathy.
    Zarich SW; Nesto RW
    Am Heart J; 1989 Nov; 118(5 Pt 1):1000-12. PubMed ID: 2683698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Metabolic Risk Factors That Affect Brain Structure.
    Caspers S
    Radiology; 2019 Jun; 291(3):772-773. PubMed ID: 31013188
    [No Abstract]   [Full Text] [Related]  

  • 8. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
    Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
    Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats.
    Bollano E; Omerovic E; Svensson H; Waagstein F; Fu M
    Int J Cardiol; 2007 Jan; 114(2):195-201. PubMed ID: 21882490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Myocardial Damage in Patients With Sarcoidosis: Is Cardiac Magnetic Resonance What We Need?
    Kim HW; Kim RJ
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005518. PubMed ID: 27621358
    [No Abstract]   [Full Text] [Related]  

  • 11. The Emerging Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Metabolic Cardiomyopathies.
    Mavrogeni S; Markousis-Mavrogenis G; Markussis V; Kolovou G
    Horm Metab Res; 2015 Aug; 47(9):623-32. PubMed ID: 26197853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeing Beyond the Obvious: Subclinical Cardiac Sarcoidosis Revealed by Cardiovascular Magnetic Resonance Mapping.
    Ferreira VM; Piechnik SK
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903542
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes: Quantifying genetic susceptibility in T1DM - implications for diagnosis after age 30.
    Meyer E; Maahs DM
    Nat Rev Endocrinol; 2018 Feb; 14(3):134-135. PubMed ID: 29422635
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
    Rijzewijk LJ; van der Meer RW; Smit JW; Diamant M; Bax JJ; Hammer S; Romijn JA; de Roos A; Lamb HJ
    J Am Coll Cardiol; 2008 Nov; 52(22):1793-9. PubMed ID: 19022158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets.
    Gilca GE; Stefanescu G; Badulescu O; Tanase DM; Bararu I; Ciocoiu M
    J Diabetes Res; 2017; 2017():1310265. PubMed ID: 28421204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
    Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitness ameliorates genetic risk of heart disease.
    Lim GB
    Nat Rev Cardiol; 2018 Jul; 15(7):380. PubMed ID: 29700401
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetic Hypertensives and Diastolic Dysfunction: Use of Calcium Channel Blockers-A Clinical Concern.
    Pareek AK; Mehta RT; Purkait I; Grover A
    JACC Heart Fail; 2017 Nov; 5(11):850-851. PubMed ID: 29096795
    [No Abstract]   [Full Text] [Related]  

  • 19. Body composition - more to fat than first meets the eye.
    Lavie CJ; Ortega FB
    Nat Rev Endocrinol; 2018 Oct; 14(10):569-570. PubMed ID: 30154527
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-invasive diagnostic imaging techniques as a window into the diabetic heart: a review of experimental and clinical data.
    Korosoglou G; Humpert PM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):211-20. PubMed ID: 17479436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.